Published in Presse Med on May 15, 1993
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
Replacement of the Bacillus subtilis subtilisin structural gene with an In vitro-derived deletion mutation. J Bacteriol (1984) 5.03
Characterization of the spo0A locus and its deduced product. Proc Natl Acad Sci U S A (1985) 4.86
Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol (1999) 4.37
The ECG in pulmonary embolism. Predictive value of negative T waves in precordial leads--80 case reports. Chest (1997) 4.29
Cloning, sequencing, and secretion of Bacillus amyloliquefaciens subtilisin in Bacillus subtilis. Nucleic Acids Res (1983) 3.70
Cloning of the neutral protease gene of Bacillus subtilis and the use of the cloned gene to create an in vitro-derived deletion mutation. J Bacteriol (1984) 3.41
Chromosomal location of a Bacillus subtilis DNA fragment uniquely transcribed by sigma-28-containing RNA polymerase. J Bacteriol (1982) 2.82
Cloning structural gene sacB, which codes for exoenzyme levansucrase of Bacillus subtilis: expression of the gene in Escherichia coli. J Bacteriol (1983) 2.73
Localization of Bacillus subtilis sacU(Hy) mutations to two linked genes with similarities to the conserved procaryotic family of two-component signalling systems. J Bacteriol (1988) 2.71
Studies of sigma D-dependent functions in Bacillus subtilis. J Bacteriol (1990) 2.53
Paternal concentrations of dioxin and sex ratio of offspring. Lancet (2000) 2.47
Isolation of Bacillus subtilis genes from a charon 4A library. J Bacteriol (1981) 2.45
Travel as a risk factor for venous thromboembolic disease: a case-control study. Chest (1999) 2.34
Identification of the pleiotropic sacQ gene of Bacillus subtilis. J Bacteriol (1986) 2.33
Effect of stage 0 sporulation mutations on subtilisin expression. J Bacteriol (1986) 2.31
De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase. J Virol (2000) 2.19
A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet (2001) 2.17
Biochemical and functional comparison of DNA polymerases alpha, delta, and epsilon from calf thymus. J Biol Chem (1991) 2.08
Generation of large libraries of random mutants in Bacillus subtilis by PCR-based plasmid multimerization. Biotechniques (1997) 2.01
Characterization of lexB mutations in Escherichia coli K-12. J Bacteriol (1977) 1.99
A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med (1997) 1.97
The genetic characterization of lexB32, lexB33 and lexB35 mutations of Escherichia coli: location and complementation pattern for UV resistance. Mol Gen Genet (1977) 1.83
Location of the targets of the hpr-97, sacU32(Hy), and sacQ36(Hy) mutations in upstream regions of the subtilisin promoter. J Bacteriol (1988) 1.74
Cloning and localization of the lepidopteran protoxin gene of Bacillus thuringiensis subsp. kurstaki. Proc Natl Acad Sci U S A (1982) 1.71
Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients. J Clin Microbiol (2000) 1.70
Effect of paraoxonase-1 polymorphism on clinical outcomes in patients treated with clopidogrel after an acute myocardial infarction. Clin Pharmacol Ther (2011) 1.67
Selective interaction of AGS3 with G-proteins and the influence of AGS3 on the activation state of G-proteins. J Biol Chem (2001) 1.64
Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase. J Virol (2000) 1.63
Characterization of the levanase gene of Bacillus subtilis which shows homology to yeast invertase. Mol Gen Genet (1987) 1.58
Impact of attenuation correction by simultaneous emission/transmission tomography on visual assessment of 201Tl myocardial perfusion images. J Nucl Med (1999) 1.57
Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol (2004) 1.56
Characterization and mapping of the Bacillus subtilis prtR gene. J Bacteriol (1987) 1.55
[Precaution in the thrombolytic treatment of myocardial infarction]. Presse Med (1989) 1.40
Intrapericardial bronchogenic cyst: an unusual cause of CA 19-9 increase. Eur J Med (1992) 1.39
[Severe early pulmonary embolism after blockage of the vena cava]. Presse Med (1994) 1.39
Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus amplicon system. J Virol (1996) 1.38
[Duration of antivitamin K therapy in venous thromboembolic disease]. Arch Mal Coeur Vaiss (1995) 1.38
Prophage induction and cell division in E. coli. V. Dominance and complementation analysis in partial diploids with pleiotropic mutations (tif, recA, zab and lexB) at the recA locus. Mol Gen Genet (1977) 1.38
Mutational analysis of bovine viral diarrhea virus RNA-dependent RNA polymerase. J Virol (1999) 1.37
Interactions of pathogenic Neisseria with host cells. Is it possible to assemble the puzzle? Mol Microbiol (1999) 1.30
p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcription. Cell Death Differ (2009) 1.30
Correlation between Bacillus subtilis scoC phenotype and gene expression determined using microarrays for transcriptome analysis. J Bacteriol (2001) 1.26
Molecular cloning of the spo0B sporulation locus in bacteriophage lambda. J Bacteriol (1982) 1.23
The X-ray structure of a recombinant major urinary protein at 1.75 A resolution. A comparative study of X-ray and NMR-derived structures. Acta Crystallogr D Biol Crystallogr (2001) 1.20
Seasonal variation in chronic heart failure hospitalizations and mortality in France. Circulation (1999) 1.19
SCH 48973: a potent, broad-spectrum, antienterovirus compound. Antimicrob Agents Chemother (1997) 1.17
Genetic and enzymic studies on the recombination process in Bacillus subtilis. Mol Gen Genet (1975) 1.16
[Treatment of primary cardiogenic shock by coronary transluminal angioplasty during the acute phase of myocardial infarction]. Arch Mal Coeur Vaiss (1990) 1.14
Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound. J Biol Chem (1995) 1.13
Physiologic variations of the internal jugular vein surface, role of the omohyoid muscle, a preliminary echographic study. Surg Radiol Anat (1988) 1.10
Four different DNA helicases from calf thymus. J Biol Chem (1992) 1.10
Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice. Cancer Res (1998) 1.10
Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants. J Am Coll Cardiol (1999) 1.10
Effectiveness of a manual disinfection procedure in eliminating hepatitis C virus from experimentally contaminated endoscopes. Gastrointest Endosc (1999) 1.09
Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study. J Clin Microbiol (2001) 1.08
Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation. J Clin Microbiol (1999) 1.08
Tick-borne infection caused by Rickettsia africae in the West Indies. N Engl J Med (1998) 1.08
Capillary electrophoresis-single-strand conformation polymorphism analysis for rapid identification of Pseudomonas aeruginosa and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1999) 1.08
Genetic contribution to idiopathic adult-onset blepharospasm and cranial-cervical dystonia. Eur Neurol (1993) 1.07
Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect (2011) 1.06
Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. Pediatrics (2001) 1.06
Resistance of human nucleotide excision repair synthesis in vitro to p21Cdn1. Oncogene (1998) 1.06
Seroprevalence of HSV-1 and HSV-2 infection in the general French population. Sex Transm Infect (2002) 1.05
Indocyanine green angiography in central serous chorioretinopathy. ICG angiography in CSC. Int Ophthalmol (1997) 1.04
Aneurysms complicating coarctation of the aorta: anatomic aspects and evolution. Report of six successful surgical cases. Thorac Cardiovasc Surg (1982) 1.04
[A clinical form of angina pectoris: Prinzmetal's angor]. Sem Hop (1969) 1.04
Thyroid function in physiological aging and in centenarians: possible relationships with some nutritional markers. Metabolism (2002) 1.04
Calf thymus DNA polymerase delta independent of proliferating cell nuclear antigen (PCNA). Nucleic Acids Res (1989) 1.03
Nucleotide sequence of the outB locus of Bacillus subtilis and regulation of its expression. J Bacteriol (1987) 1.03
Studies on transduction process by SPP1 phage. J Gen Virol (1978) 1.03
Cytomegalovirus seroprevalence in French pregnant women: parity and place of birth as major predictive factors. Eur J Epidemiol (1998) 1.03
Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide. Transplant Proc (1996) 1.02
HIV-1 in blood monocytes: frequency of detection of proviral DNA using PCR and comparison with the total CD4 count. AIDS Res Hum Retroviruses (1992) 1.02
Effects of different types of exercise training followed by detraining on endothelium-dependent dilation in patients with recent myocardial infarction. Circulation (2009) 1.01
Traumatic aortic regurgitation: aortic valvuloplasty controlled by aortoscopy. J Heart Valve Dis (2001) 1.01
Do DNA polymerases delta and alpha act coordinately as leading and lagging strand replicases? FEBS Lett (1988) 1.01
[The treatment of brucellosis using rifampicine (author's transl)]. Nouv Presse Med (1979) 1.00
Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection. J Gen Virol (1994) 1.00
DNA polymerase switching: II. Replication factor C abrogates primer synthesis by DNA polymerase alpha at a critical length. J Mol Biol (2000) 0.99
Effects of diet-therapy on urinary protein excretion albuminuria and renal haemodynamic function in obese diabetic patients with overt nephropathy. Int J Obes (1989) 0.97
[Guidelines for good clinical practice: prevention and treatment of venous thromboembolism in medical patients]. J Mal Vasc (2010) 0.96
Solution structure of a recombinant mouse major urinary protein. Eur J Biochem (1999) 0.95
The relA locus and the regulation of lysine biosynthesis in Escherichia coli. Mol Gen Genet (1980) 0.95
Changes of serum allopregnanolone levels in the first 2 years of life and during pubertal development. Pediatr Res (1999) 0.95
Clinical epidemiology of venous thromboembolic disease. Results of a French Multicentre Registry. Eur Heart J (1997) 0.94
The p15 carboxyl-terminal proteolysis product of the human immunodeficiency virus type 1 reverse transcriptase p66 has DNA polymerase activity. Proc Natl Acad Sci U S A (1991) 0.94
Conversion of an androgen epoxide into 17beta-estradiol by human placental microsomes. Biochemistry (1975) 0.93